MC38-hSIGLEC15 (2)

Export PDF

Strain Information

Cell Line

MC38-Tg(hSIGLEC15)Smoc

Cat. NO.

NM-S13-TM88

Model Description

SIGLEC15 gene humanized mouse colon adenocarcinoma cell.

Strain State

Validation of pharmacodynamic assays completed

Validation Data

image.png 

Figure 1. hSIGLEC15 expression in MC38-hSIGLEC15 cell line

image.png 

Figure 2. Tumor growth curve of MC38-hSIGLEC15 syngeneic model (n=6)

image.png 

Figure 3. Body weight change of MC38-hSIGLEC15 syngeneic model (n=6)

image.pngFigure 4. The expression of hSIGLEC15 in humanized modified tumors by FACS


Related Strain(s)

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more